The Effectiveness of Cancer Pain Management in a Tertiary Hospital Outpatient Pain Clinic in Thailand: A Prospective Observational Study

Table 4

Pain interferences and other symptoms’ difference between pain responders and nonresponders at FU3.

	Pain responders (n = 44)	Nonresponders (n = 28)	value
BPI, pain interference, median (IQR)
General activity	6.0 (4.0–9.5)	6.0 (2.5–8.0)	0.276
Mood	6.0 (2.5–8.0)	5.0 (2.0–7.5)	0.496
Walking ability	5.0 (2.5–8.0)	5.5 (2.5–8.0)	0.780
Normal work	6.0 (2.5–10.0)	5.0 (3.0–8.0)	0.548
Relations with others	4.5 (0.5–7.0)	4.5 (1.0–6.5)	0.986
Sleep	7.0 (4.5–8.5)	7.0 (4.0–8.0)	0.954
Enjoyment of life	6.0 (2.0–9.0)	5.0 (2.0–8.0)	0.481
BPI total score	40.5 (26.0–52.5)	39.5 (25.5–46.5)	0.591
ESAS, symptoms, median (IQR)
Pain	4.0 (2.5–5.0)	5.0 (2.5–7.0)	0.085
Fatigue	4.5 (2.0–6.5)	5.0 (2.0–6.0)	1.000
Nausea	0.0 (0.0–2.0)	0.5 (0.0–3.0)	0.489
Depression	0.0 (0.0–2.5)	0.0 (0.0–3.5)	0.732
Anxiety	2.5 (0.0–5.0)	3.0 (1.0–5.0)	0.262
Drowsiness	2.5 (0.5–5.0)	3.0 (0.5–5.0)	0.806
Appetite	3.5 (0.0–7.5)	4.0 (1.0–5.5)	0.774
Well-being	3.5 (0.0–7.0)	5.0 (0.5–5.5)	0.986
Shortness of breath	2.0 (0.0–5.0)	3.0 (0.0–5.5)	0.569
ESAS total score	26.5 (15.5–42.0)	30.0 (18.0–44.0)	0.595

at follow-up compared to baseline using Mann–Whitney U test. FU: follow-up; BPI: Brief Pain Inventory; ESAS: Edmonton Symptom Assessment System.